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Harnessing photochemical internalization with
dual degradable nanoparticles for combinatorial
photo–chemotherapy
George Pasparakis1,2,*, Theodore Manouras1,3,*, Maria Vamvakaki1,4 & Panagiotis Argitis3
Light-controlled drug delivery systems constitute an appealing means to direct and conﬁne
drug release spatiotemporally at the site of interest with high speciﬁcity. However, the
utilization of light-activatable systems is hampered by the lack of suitable drug carriers that
respond sharply to visible light stimuli at clinically relevant wavelengths. Here, a new class of
self-assembling, photo- and pH-degradable polymers of the polyacetal family is reported,
which is combined with photochemical internalization to control the intracellular trafﬁcking
and release of anticancer compounds. The polymers are synthesized by simple and scalable
chemistries and exhibit remarkably low photolysis rates at tunable wavelengths over a large
range of the spectrum up to the visible and near infrared regime. The combinational pH and
light mediated degradation facilitates increased therapeutic potency and speciﬁcity against
model cancer cell lines in vitro. Increased cell death is achieved by the synergistic activity of
nanoparticle-loaded anticancer compounds and reactive oxygen species accumulation in the
cytosol by simultaneous activation of porphyrin molecules and particle photolysis.
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M
odern nanomedicines promise to revolutionize cancer
diagnoses and therapies by intervening to diseased
tissues at the nanoscale and biomolecular level. The
major advantage that nanoscale drug delivery systems (DDS)
exhibit is the inherent passive tumour-targeting properties
primarily derived by the enhanced permeation and retention
effect attributed to the presence of leaky and ill-deﬁned
vasculature network and the lack of lymphatic drain1. Equally
important is the possibility of active tumour targeting by the
installation of recognition motifs on the surface of the
nanoparticles (that is, speciﬁc cancer recognition markers,
antibodies, and so on.)2,3. In addition, nanoparticulate DDS
allow for simultaneous carriage of chemical substances such as
anticancer agents and bio-imaging tags and have been proposed
as an emerging platform in cancer theranostics4. The therapeutic
beneﬁt of polymeric DDS in tumour targeting through systemic
administration has been demonstrated by numerous studies
utilizing bioactive materials, including block copolymers,
nanogels, and organic/inorganic hybrids, under various thera-
peutic scenarios such as against multi-drug resistant tumours5–7.
Although considering design parameters to mediate passive
and/or active tumour targeting is of paramount importance to
maximize the accumulation of nanoparticles (NPs) to tumour
sites, intracellular barriers must also be considered to ensure drug
release speciﬁcity at the organelles of interest8; effective
endosomal escape is crucial to target the therapeutic cargo to
speciﬁc cellular compartments. An appealing approach is the use
of stimuli responsive DDS that exhibit sharp drug release changes
in the presence of physiological gradients (that is, endosomal pH
drop) or externally-controlled triggers such as temperature
changes or light activation9,10. Light11, in particular, is a
convenient means to externally activate DDS as it is generally
safe, versatile – a wide range of wavelengths can be used – and
can be delivered to nearly all parts of the body via catheterization
or external sources12. Major obstacles, however, hamper the
application of photocontrolled DDS in clinical use which include
(i) the poor tissue penetration of certain wavelengths especially in
the ultraviolet regime owing to extensive tissue absorbance and
back scattering, (ii) the use of deep tissue penetrating wavelengths
(in the near infrared regime) often requiring extensive focusing to
achieve high (and potentially phototoxic) photon ﬂux, which is
not suitable for large tumour areas (see ref. 13 for a typical laser
therapy protocol) and (iii) the lack of suitable drug carriers with
high light-sensitivity14. In fact, the vast majority of studies on
light-responsive DDS use ultraviolet A sources for activation (that
is, wavelengths below 400 nm) and even when multi-photon
excitation is employed, focused laser sources of high ﬂuencies are
used with limited working laser volume, up to a few micrometres
only. Despite the substantial progress in light-responsive
materials and biomolecular systems, and their applications in
diverse areas, such as dynamic cell culture15–17,
microfabrication18,19 and bioimaging20, the necessity of
introducing new photochemistries that pragmatically address
the aforementioned obstacles is of paramount importance for
these technologies to realize their clinical potential in the context
of modern therapeutic and diagnostic modalities.
To this end, we envisioned that photochemical internalization
could serve as a model light–matter interaction motif in biological
systems to challenge new photochemistries. Photochemical
internalization (PI) is a conceptually powerful tool that was
introduced to actively control the intracellular trafﬁcking of
anticancer agents via an exogenously applied optical stimulus,
which allows for spatiotemporally-controlled drug release and
trafﬁcking. PI is applied by the codelivery of a bioactive agent (for
example, a drug molecule) with a photosensitizer (for example, a
porphyrin molecule) which upon cellular uptake is activated by a
laser source21,22. In turn, the photosensitizer produces reactive
oxygen species (ROS), which disrupt the membrane of the
endosomal compartment and allow for effective escape of the
drug molecules to the cytosol. PI has been successfully applied for
the delivery of both high molecular weight (such as proteins and
nucleic acids)23–25 and low molecular weight anticancer agents
(such as camptothecin (CPT))26 under various therapeutic
scenarios.
In the present study, we demonstrate for the ﬁrst time, the
application of PI in combinatorial photo–chemotherapy against
cancer cells using a new class of dual degradable NPs coloaded
with a potent chemotherapeutic anticancer compound (CPT) and
a phototoxic drug (hematoporphyrin (HP)). Our system can be
activated using visible, and potentially infrared wavelengths at
very low doses delivered as unfocused pulse cues and exhibits
simultaneous photo- and chemo-degradations, ideal for concerted
light- and pH-controlled intracellular trafﬁcking of drug cocktails,
allowing for aggressive photo-induced cancer cell death. The
proposed system induces enhanced cell death rates against cancer
cells in vitro, owing to the concerted photo–chemotherapeutic
potency of the drug cocktail over a wide surface area by laser
activation using a clinically relevant light dosage protocol.
Results
Polymer synthesis and characterization. Considering the limit-
ing factors that somewhat prevent the development of photo-
sensitive nanomedicines (vide supra) we set out key design
criteria to render the nanomaterials broadly addressable in the
biomedical context: (i) simple chemistries were established so that
the designed polymers are scalable and versatile for further
optimization and formulation via self-assembly, (ii) we developed
a mild photolysis strategy to allow for substantial red-shifting of
the irradiation beam towards the visible and, if possible, the near
infrared regime without compromising the laser working volume
and (iii) we explored the possibility of loading drug cocktails
(including poprhyrin molecules) to induce multimodal drug
release against cancer cell lines via the photochemical inter-
nalization pathway.
We recently reported on a new class of polymers based on the
ketal family27 that exhibits remarkably low ablation thresholds
owing to their very low photolysis threshold, at least one order of
magnitude lower compared with the heavily studied o-nitrobenzyl
or other ultraviolet/visible labile materials28–32.
Acetals have a well established hydrolysis proﬁle under the
mildly acidic conditions (pH 5.5) found in the late endosome33,34.
In an effort to introduce red-shifted photo-lability on the
backbone of the polymer in the visible, a 2-nitroresorcinol
comonomer was used.
The polymer was synthesized from commercially available
synthons by a two-step acid catalysed polycondensation reaction
of the 2-nitroresorcinol monomer with a divinyl ether derivative
(ﬁrst step), which was subsequently end-capped with poly(ethy-
lene glycol) (PEG) (Fig. 1a) at the vinyl ends of the semitelechelic
precursor polymer (second step). The precursor polymer was
synthesized by mixing the two monomers at equimolar amounts
in the presence of pyridinium p-toluenesulfonate (PPTS, 1%) as
catalyst, and was isolated in a relatively good yield (55%) before
characterization by proton nuclear magnetic resonance spectro-
scopy (1H NMR) (Supplementary Fig. 1) and gel permeation
chromatography (GPC) (Supplementary Fig. 2). Then, the
polymer was end-capped with monohydroxy terminated PEG
(2 kDa) again catalysed by PPTS (1%) to afford the ﬁnal block
copolymer structure (Fig. 1a, and experimental section). The ﬁnal
product was isolated in good yield (ca. 80%) and characterized by
GPC and 1H NMR (Supplementary Fig. 3 and Fig. 3a). The Mn of
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the polymer was found to be ca. 5,000 by GPC with a
polydispersity index of 1.6, typical for polycondensation poly-
merizations. The ﬁnal block copolymer consisted of a 2 kDa PEG
block and a polyacetal block of ca. 9 acetal repeating units, which
served as a self-assembled photo- and pH-labile block copolymer
for multi-stimulus-activated drug release (Fig. 1c). The synthetic
route that was followed involved the reaction of the divinyl and
bis-hydroxyl monomers in a 1:1 molar ratio. The reaction kinetics
of the polymerization is governed by step growth propagation35,36
where the starting monomers form dimers, which further react to
form tetramers and so forth. Hence, the main product of the
precursor polymer is a semitelechelic product with one vinyl and
one hydroxyl end which, in theory, prevents the formation of
triblock segments in the second step. Hence, further reaction with
the PEG-hydroxyl should yield a di-block copolymer as the main
product. In practice, the possibility of a triblock forming during
the polymerization reaction cannot be neglected. However, from
the GPC trace we do not see the formation of higher molecular
weight products other than the ﬁnal di-block copolymer and even
if the triblock copolymer is present in a minute quantity it will
also behave as a polymeric amphiphile and participate in the self-
assembly process for the NP formation.
Polymer photolysis at 365 nm. Photodegradation studies were
ﬁrst conducted in the solid phase by preparing thin polymer ﬁlms
on silicon substrates (400 nm ﬁlm thickness). Upon light expo-
sure with a Hg–Xe tool adjusted at 365 nm, effective photolysis of
the ﬁlms was evidenced by ultraviolet/visible and Fourier trans-
form infrared (FT-IR) spectroscopy (Fig. 2a,b). Distinct absorp-
tion peaks appeared in the ultraviolet/visible spectrum of the
irradiated sample, corresponding to the formation of carbonyl
(250 nm) and nitroresorcinol photoproducts (330 nm). The
photolysis mechanism was further corroborated by FT-IR spec-
troscopy where peaks at 3,400 cm 1 (broad) and 1,740 cm 1
appeared in the spectrum of the exposed sample, indicative of the
formation of hydroxyl and carbonyl photoproducts. In addition,
there was a noticeable change of the spectrum at 1,000–
1,150 cm 1 assigned to the ether C-O-C stretching, overlapping
with the cleavage of the acetal O-C-O bonds. The photolysis
process is hypothesized to be triggered by direct zwitterionic
cleavage of the acetal proton followed by acid hydrolysis and
formation of the starting 2-nitroresorcinol, acetaldehyde and
cyclohexyl di-alcohol byproducts (Fig. 1b).
Photolysis of acetal (Ac1) and photoproduct characterization.
To further elucidate the photolysis mechanism, we synthesized a
low molecular weight compound resembling the repeating unit of
the polymer, in an effort to characterize the photolysis products
by mass spectrometry. The molecule Ac1 (Supplementary Fig. 4)
was subjected to complete photodegradation by ultraviolet
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Figure 1 | Synthesis, degradation and self-assembly properties of the block copolymer. (a) Synthetic route of the polycondensation reaction. For the
precursor polymer, 2-nitroresorcinol and cyclohexyl divinyl ether were added in equimolar amounts with 1% PPTS (THF, N2, 12 h, 55% yield). For
the block copolymer, 2 kDa PEG monohydroxy terminated was used with 1% PPTS (see experimental section for the detailed description), (b) the dual
stimulus-mediated degradation of the polymers occurs either by ultraviolet/visible photolysis by single (365 nm), double (532 nm) or multi
(1,064 nm, Supplementary Fig. 8) photon excitation, or acidolysis at mildly acidic pH (ca. 5.2) and (c) our proposed generalized strategy involves the
self-assembly of the block copolymers in aqueous solutions, which allows for efﬁcient loading of drug cocktails (that is, CPT and HP) that can be
released by application of mild light irradiation and/or owing to the intracellular pH drop in the late endosomes upon cellular uptake.
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irradiation at 365 nm and the photoproducts formed were studied
by 1H NMR and gas chromatography–mass spectrometry (GC–
MS). From the 1H NMR spectrum, it was possible to clearly trace
the formation of acetaldehyde, 2-nitrophenol and the aliphatic
alcohol derivative, which are the main photoproducts, along with
the complete disappearance of the acetal proton as a result of the
quantitative photolysis (Supplementary Fig. 5). The possible
formation of carbonyl-rich photoproducts was evident in the
1.5–2.1 p.p.m. range of the 1H NMR spectrum, which could be
conﬁrmed by GC–MS (Supplementary Figs 5 and 6). The latter
conﬁrmed the formation of the 2-nitrophenol and the aliphatic
di-alcohol, however it was not possible to trace acetaldehyde,
presumably owing to its low molecular weight, below the detec-
tion limit of the instrument. It should be noted that the fact that
2-nitrophenol is unambiguously traced by both 1H NMR and
GC–MS, excludes the possibility of formation of other nitroso
derivatives, which in turn conﬁrms our proposed mechanism
of acetal photolysis involving the zwitterion37 intermediate
formation as proposed in Fig. 1b.
We also used Ac1 as a model molecular probe to monitor the
photolysis kinetics by following the gradual diminution of the
acetal proton peak as a function of the irradiation time
(Supplementary Fig. 7); it is apparent that the photolysis
progresses by a non-linear parabolic rate and reaches 100% at a
total irradiation dose of 1 J. To sum up, the main photoproducts
comprise the formation of acetaldehyde, 2-nitrophenol and
cyclohexyl di-alcohol products; carbonyl-rich photoproducts are
also evident but these should exist at minute quantities and are
not uncommon in photolysis studies.
Two-photon polymer photolysis. Encouraged by these results,
we studied the two-photon photolysis properties of the polymer
in the solid and liquid phase. The second harmonic of a neody-
mium-doped yttrium aluminium garnet (Nd:YAG) laser (532 nm,
7 ns pulse duration) was chosen for the red-shifted photolysis
experiments as it is currently used in the clinic and exhibits
adequate tissue penetration depth38. Nearly complete photolysis
of the polymer ﬁlm was observed after laser irradiation with a
single unfocused pulse with energy ﬂuence as low as 20mJ cm 2
(Fig. 2c). The ﬁlm ablation was effective across the whole area of
irradiation, which was evident from the pattern formation by
application of a photomask (Fig. 2c and d). Characteristic Fresnel
diffraction patterns were observed on the residual debris
indicating that the pulse energy was close to the ablation
threshold. It should be noted that near ﬁeld diffraction is found
in multi-photon excitation processes using unfocused laser
sources39.
The photolysis of the polymer in solution was conducted in
deuterated chloroform to allow for direct monitoring of the
photodegradation by 1H NMR. The polymer solution was
irradiated with 20mJ cm 2 pulses for 10 s with frequency of
5Hz and a total energy dose adjusted at 1 J so that the photolysis
protocol is clinically valid for photodynamic therapy, but also to
maximize the potency of the photolysis process. The NMR
spectrum of the laser-exposed sample clearly showed the
formation of acetaldehyde and 2-nitroresorcinol, and the
simultaneous decrease of the acetal proton peak at 4.5 p.p.m. as
a result of the photocleavage of the photolabile polymer block
(Fig. 3a). The photolysis process was ca. 70% complete judging
from the relative integrals of the acetal peaks with respect to the
non-exposed sample (see experimental section for details). We
attribute the incomplete photodegradation to the absence of water
in the sample, which is necessary for more effective photo-
degradation and to the inhomogeneous irradiation of the sample
by the laser beam. Nevertheless, the effect of laser photolysis was
visible with the naked eye as the polymer solution gradually lost
its vivid yellow colour during laser irradiation (Fig. 3c).
Drug release studies. Having established the photolysis condi-
tions at 532 nm, drug release studies were performed to optimize
the conditions for PI. The polymer formed spherical nano-
particles in water with mean diameter of 190 nm determined by
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Figure 2 | Polymer thin ﬁlm photolysis studies. (a) Characteristic ultraviolet/visible and (b) FT-IR spectra of the non-exposed and exposed polymer
ﬁlms at 365 nm radiation demonstrating typical absorbance and transmittance peaks of the photoproducts formed, (c) optical microscopy image
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dynamic light scattering (DLS) (equation (2), Supplementary
Fig. 9). The morphology of the nanoparticles was examined by
transmission electron microscopy (TEM), which conﬁrmed their
spherical shape and their relatively uniform size distribution
(Fig. 3b). Close inspection of the nanoparticles revealed an aro-
matic-rich core indicative of the strong electron-rich signal in the
TEM micrographs (darker areas), whereas the hydrophilic PEG
residues appeared in lighter grey colour. The nanoparticles were
found to be stable for weeks in slightly alkaline solutions (that is,
in PBS pH 7.4 to prevent acetal hydrolysis).
CPT was combined with HP to induce multimodal-type cell
death and to apply PI as a drug codelivery modality activated by
concerted pH and light stimuli (Fig. 1c). HP is a widely used
photosensitizer that produces ROS on light exposure of various
wavelengths owing to the broad-absorbing band of porphyrin
molecules. CPT is a potent alkaloid that interacts with DNA and
topoisomerase I and leads to apoptotic cell death. CPT is
hydrophobic and could be incorporated in the lipophilic core of
the NPs; in addition, CPT encapsulation limits the possibility of
possible opening of the lactone ring, which could compromise its
activity. HP is also hydrophobic and can be loaded in the cores of
the NPs, however, its water solubility can be tuned by varying the
pH owing to the presence of the carboxyl groups adjacent to the
porphyrin ring. HP and CPT have distinct emission proﬁles when
excited at 350 nm (Supplementary Fig. 10), which was convenient
to quantify the drug loading (equation (1)) capacity of the
nanoparticles (17% and 11% for CPT and HP, respectively). CPT
was used as a reference compound to monitor the drug release
rates as a function of pH variation and laser irradiation.
Relatively low drug leakage from the NPs was recorded at
alkaline pH, which did not exceed 15% of the total-loaded CPT
after 4 h, which was indicative of the acetal bonds’ resistance to
hydrolytic cleavage (Fig. 3c). Under the same conditions, laser
irradiation resulted in nearly double CPT release (26%) as a result
of the partial NPs’ photolysis.
Conversely, the drug release rate was signiﬁcantly more
pronounced when the pH was lowered to 5.2, which is the pH
found in the late endosome where PI takes place. The total CPT
release reached 52% in the non-irradiated sample as a result of
the hydrolysis of the NPs. The CPT release was dramatically
increased upon laser exposure and exceeded 90% as a result of the
combinational NPs’ photo-acido-lysis.
It is also apparent that the acidic samples exhibit an initial
burst-type drug release in the ﬁrst 20min and then the slope of
the rate of CPT release is signiﬁcantly lower (Fig. 3c). This is
attributed to the fact that the polymer hydrolysis should be
initiated from the acetal moieties adjacent to the hydrophilic PEG
block, which enhances their solvation and hence their suscept-
ibility to acid hydrolysis. Then the hydrolysis rate should be
governed by the less solvated NP core and is subjected to acidic
hydrolysis at a lower rate, which is reﬂected to the CPT-release
proﬁle.
Preliminary cytotoxicity studies. Cytotoxicity studies were
performed by collecting CPT samples at the end of the drug
release experiments (after 4 h, Fig. 3c) to probe the effect of
diffusive- or stimulus-mediated (pH and/or light) CPT release on
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HeLa cells (Supplementary Fig. 11). The minute CPT leakage
after 4 h induced limited cell death in both alkaline,
non-irradiated (8%) and irradiated (12%) samples; the cell death
rates were found to be statistically insigniﬁcant and hence we
presume that the CPT released from these samples should be well
below the IC50 onset for effective cytotoxicity. The death rates
signiﬁcantly increased in the case of the acidic samples (27% and
54%, for the non-irradiated and irradiated sample, respectively) as
a result of the more pronounced CPT release owing to the
acidolysis (or combined acido-photo-lysis) of the NPs, which
resulted in 52 and 91% release of total-loaded CPT (Fig. 3c).
These results underline the fact that the minor CPT leakage from
the dormant NPs (alkaline, non-irradiated) exerts very low
cell death rates compared with the activated NPs (acidic and
irradiated) and hence support our drug loading and release
methodology in the proposed context of laser-mediated
intracellular activation of the NPs.
Cellular uptake and photochemical internalization. Similar
experimental conditions were applied for the in vitro studies to
prove the concept of using chemo- photo-degradable NPs in PI
protocols.
Subsequently, CPT- and HP-loaded NPs were incubated with
HeLa cells for 4 h and their cellular uptake using ﬂuorescence
microscopy were examined. The cellular uptake was signiﬁcantly
higher (62%) in the case of the drugs being loaded in NPs than
the non-encapsulated HP and CPT controls (35% and 29%,
respectively, Fig. 4a). This is attributed to the hydrophobic nature
of both CPT and HP molecules, which results in non-speciﬁc
binding to the proteins of the culture medium and in turn
compromises the cytoplasmic entrance by the lowering of their
effective concentration for cellular uptake. Additionally, it is well-
documented that nanoparticles in the size range of 100–200 nm
(as in this study), are preferably uptaken by the endosomal
pathway via clathrin-dependent endocytosis, which is a relatively
fast process (compared with the macropinocytotic pathway)40,41.
The cellular uptake of the NPs was visible under the ﬂuorescence
microscope by tracking the strong red emission of HP (Fig. 4b)
via excitation of the Soret band at 400 nm.
Finally, the resazurin assay was performed to evaluate the
possible toxicity of the polymer and its photoproducts as well as
the potency of laser irradiation in cell death of the drug-loaded
NPs against various controls. The polymer was found to exhibit
minimum cell toxicity when tested in similar concentrations to
the actual drug-loaded formulation, but more importantly, the
photolysed material also showed minute toxic effects in vitro
(Fig. 4c). Laser irradiation studies were performed by using
continuous wave (CW) and pulsed lasers to rule out possible
effects of single- or multi-photon phototoxic events but also to
probe the role of particle photodegradation in the overall cell
death mechanism. The total dose delivered to cells was
determined to be 1 J and was delivered by unfocused pulsed cues
with an effective area of 0.7 cm2 to maximize the effective laser
area. Strikingly, the cell death rate was considerably higher
(exceeded 93%, Fig. 4c) in the case of NPs irradiated with the
YAG laser at 532 nm compared with all other controls, namely,
CPT or HP alone, and CPT/HP combined but not NP loaded.
Also, minor death rates, presumably owing to phototoxic events,
were observed by using lasers only without the presence of drugs
under the followed irradiation protocol. Interestingly, the type of
laser does not seem to have a statistically signiﬁcant effect on any
of the controls used except for the drug-loaded NPs were the
particle photolysis seems to enhance the cell death rates by 30%
compared with the CW-irradiated NPs (65%) where no
synergistic particle photolysis takes place (Fig. 4c).
It is noteworthy to analyse the mechanism of action of the
system developed to understand the potency of its cytotoxicity
(Fig. 5). First, the NP compartment allows for simultaneous
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delivery of two active agents, CPT and HP, which are in close
proximity during the delivery events. NPs are presumably
uptaken by cells via the endocytosis pathway and end up in the
late endosome. The gradual acidiﬁcation of the late endosomal
compartment leads to partial hydrolysis of the NPs, which is
augmented by the laser photolysis. The particle degradation is
followed by drug liberation and association of CPT and HP with
the endosomal membrane. In particular, protonation of the HP
molecules (two pK values are found in the pH range 2.9–11.3,
namely pK 5.7 and 8.2 (ref. 42)) in the acidic environment
increases their lipophilicity leading to more pronounced
interaction with the endosomal bilayer. Then, laser activation
results in singlet oxygen production via photosensitization of the
HP molecules, which in turn disrupt the endosomal membrane,
assisting CPT molecules to escape from the compartment and
trigger cell death pathways. In essence, the cell death is concerted
by the synergistic excessive ROS accumulation and the enhanced
CPT release from the endosome during laser treatment. However,
it is detrimental to ensure that both drugs are in close proximity
to exert ampliﬁed cell death rate, which apparently, is not
observed when the two drugs are delivered simultaneously but
without being loaded in NPs (Fig. 4c).
It should be noted that secondary mechanism pathways of
action may exist; for example, it is possible that a small fraction of
particles are photolysed before they reach the acidic environment
of the late endosome (that is, in lysosomes), but still contribute to
the ROS generation and CPT liberation. Therefore, to fully
deconvolute the role of pH versus light irradiation on the
intracellular trafﬁcking of the drug cocktail, a detailed biophysical
study will be required in the future to track the NPs’ intracellular
pathways via confocal microscopy.
Discussion
Photodegradable materials29 have only recently emerged as a new
means to exogenously manipulate living matter and control
biological processes. Notable applications include dynamic cell
culture, scaffold biofabrication, cell patterning technologies and
biomolecule microarray construction. Although, the chemical
repertoire for caging (and photo-unmasking) small molecules has
been extensive11, the application of such photochemistries in
drug delivery technologies has been rather limited. Ultraviolet
light sources provide poor tissue penetration depth and usually
multi-photon excitation requires highly focused laser beams that
somewhat limit the clinical potential of these systems. Our
approach involves the use of novel-type photolabile
chromophores that absorb in the visible regime and comprise
acetals as the labile moieties that exhibit very low ablation
threshold, which is signiﬁcantly lower than polyesters, styrenics
and polytriazenes, among other materials, and is the only class of
polymers with such low photolysis thresholds with visible
irradiation43. Our strategy, allows for facile tuning of the
irradiation wavelength depending on the adjacent chromophore
to the acetal unit. Hence the photolysis process can be triggered
by using either ultraviolet (193 and 248 nm)27, ultraviolet A
(365 nm), visible (532 nm) and near infrared (1,064 nm,
Supplementary Fig. 8) light sources either by single, double, or
multi-photon excitation. Furthermore, the concerted photo and
chemo-lability of the polymers render them ideal carriers to apply
PI protocols to overcome biological barriers and target speciﬁc
cellular organelles. In addition, the polymers developed in this
study serve as excellent multi-drug carriers as they form
nanoparticles with aromatic-rich cores, which can safely host
combinations of hydrophobic drugs and photosensitizers via p-p
stacking and/or hydrophobic interactions with minute leakage.
Drug coencapsulation in nanoparticulate matrices constitutes an
alternative method to deliver drug and biologics using PI and
complements direct conjugation methods where the drug of
interest is covalently linked with a photosensitizer.
It is envisaged that the combination of PI with photodynamic
therapy will circumvent the inherent difﬁculties in certain tumour
types where drug resistance limits the therapeutic outcome of
classic chemotherapy. In this context, the development of suitable
drug carriers and chemistry motifs to deliver drug cocktails that are
exogenously activated at speciﬁc diseased sites at large tissue areas
is of paramount clinical importance. The extremely low ablation
threshold of these materials, allows for signiﬁcant widening of the
laser working volume to the millimetre or even the centimetre scale
which opens new possibilities in medically-related photochemis-
tries to be applied at the macroscale, for example, in laser-mediated
tumour ablation, and laser/image-guided drug delivery and
surgery. In addition, the main-chain scission type of combined
polymer photo-acido-lysis leads to the formation of non-toxic low
molecular weight photoproducts, which render the system
appealing from a pharmacological viewpoint.
In a wider context, the formulation of multifunctional
nanomedicines (including multiresponsive DDS) for therapy
and imaging poses tremendous challenges in terms of therapeutic
value in respect to manufacturing cost and toxicity issues4. One
approach to circumvent these limitations is the introduction of
DDS constructed by a limited number of building blocks that
exert multiple biological/therapeutic activities via rational design
principles. For example, in the present study we demonstrated
that by a dual stimulus mechanism, it is possible to induce
effective PI-based drug delivery via the rational coupling of the
nanocarriers’ properties with the drug cocktail. In essence, the
proposed DDS responds in four different, but synergistic,
mechanisms triggered by two stimuli: the pH drop induces
simultaneous polymer degradation and change in the lipophilicity
of HP, while the application of laser irradiation induces polymer
photolysis and ROS production to mediate PI.
We feel that the materials developed in this study will certainly
open up new avenues in the development of such combinational
therapeutic modalities and will fuel the ﬁeld of light-controlled
DDS to complement the landscape of exogenously-activated
DDS, which are currently limited to thermal (that is, Thermo-
dox44) or magnetic (that is, Magforce45) means of activation.
In conclusion, we have developed new materials that exhibit
mild and tunable photolytic cleavage under clinically relevant
conditions. We demonstrated the use of dual photo- and chemo-
degradable NPs in photochemical internalization-mediated
delivery of cytotoxic agents and proved the concept of enhanced
cytotoxicity against cancer cell lines in vitro. The block copolymer
NPs were synthetized using scalable synthetic strategies and we
managed to red-shift the photolysis wavelength to the visible
regime but also to keep the photolysis threshold at low ﬂuencies.
Polyacetals were subjected to single, double and multi-photon
laser photolysis which, in combination with the acidic degrada-
tion, was shown to simultaneously control the intracellular
activation and release of drug cocktails and mediate ampliﬁed
cancer cell cytotoxicity. Finally, it is encouraging that the
developed chemistry is also applicable in the infrared regime
which, after further optimization of the labile chromophores, will
pave the way for in vivo studies.
Methods
Materials and instrumentation. All solvents and reagents were purchased from
Sigma or Alfa Aesar and were of analytical or HPLC grade. Gel permeation
chromatography was carried out using a Thermo Scientiﬁc Spectrasystem P1000
isocratic pump equipped with a ultraviolet and refractive index detector and mixed
D and mixed E columns. The molecular weights of the polymers were determined
by the universal calibration method using polystyrene standards. Tetrahydrofuran
(THF) at a ﬂow rate of 1mlmin 1 was used as the mobile phase. NMR studies
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were carried out on a Bruker Advance DPX 300 NMR Spectrometer (300MHz).
Ultraviolet/visible spectroscopy was performed using a Perkin-Elmer spectro-
photometer. FT-IR studies were carried out using a Bruker, Tensor 27 spectro-
meter. An Oriel 500 W Hg-Xe lamp was used for the photodegradation studies.
A Nd:YAG nanosecond laser (7 ns pulse duration) was used for the cell photolysis
experiments. Optical microscopy was performed on a Leica DMRM microscope
equipped with a digital camera connected to a PC. GC–MS was carried out on a
Shimadzu GC–MS-QP2010 Ultra spectrometer.
Precursor polymer synthesis. In a typical polymerization reaction, 2 g
(0.013mol) of 2-nitroresorcinol were dissolved in 20ml dry THF under magnetic
stirring in a 50ml round bottom ﬂask sealed with a rubber septum. A THF aliquot
of 1,4-cyclohexanedimethanol divinyl ether (2.77ml, 0.013mol) was transferred in
the ﬂask through a glass syringe. The polymerization reaction was initiated by
adding 1% PPTS (0.033 g, 0.13mmol, molar equivalent with respect to the
monomers) in the THF solution, which was left under stirring for 12 h in the dark.
The reaction was stopped by adding 1–2 drops of triethylamine to quench the
catalyst. The polymer was isolated by precipitation in hexane followed by extensive
drying under vacuum to constant weight. The polymer was obtained as a pale
yellow oil (yield 55%).
Block copolymer synthesis. The precursor polymer (2,800MW) was reacted with
a monoydroxy PEG derivative of 2,000Da as follows. 2 g PEG were dissolved in dry
THF (10ml) and then transferred to a freshly-prepared polymer solution (10ml
THF, 2.8 g precursor polymer). 1% PPTS with respect to the total polymer moles
was added to initiate the reaction, which was left under stirring in the dark for 24 h.
The reaction was stopped by adding 1–2 drops of triethylamine. The ﬁnal product
was collected by precipitation in hexane followed by extensive drying under
vacuum to constant weight. Extensive dialysis against THF was performed to
isolate the block copolymer from the unreacted PEG and lower molecular weight
byproducts (Supplementary Fig. 1). A regenerated cellulose membrane with
molecular weight cut-off (MWCO) 3,500Da was used throughout the puriﬁcation
process before characterization with GPC and NMR (Supplementary Fig. 2).
Synthesis of 2-nitrobenzene-2-ethylhexyl methyl Ac1. The acetal-containing
compound was synthesized by the electrophilic addition of 2-nitrophenol (1.2 g,
8.64mmol) and 2-ethylhexyl vinyl ether (1.38ml, 7.2mmol) in dry THF (10ml).
The reaction was initiated by the addition of PPTS (18mg, 0.072mmol) and was
left at 50 C for 24 h. The reaction was stopped by the addition 0.1ml of triethy-
lamine and the THF was removed using a rotary evaporator. The reaction mixture
was then transferred to dichloromethane and the product was isolated by washing
ﬁve times with water to remove the excess of 2-nitrophenol and the catalyst.
Removal of the dichloromethane afforded the ﬁnal product as a yellow oil (1.4 g,
yield 66%), which was then characterized by 1H NMR and GC–MS along with its
photoproducts.
Polymer ﬁlm preparation and laser irradiation. Thin polymer ﬁlms were pre-
pared by spin coating a polymer solution (5% in THF) on silicon wafers
(1,000 r.p.m., 1min). The polymer ﬁlms were extensively dried using N2 steam and
stored in the dark before use. The ﬁlm thickness was measured by ellipsometry and
was found to be ca. 400 nm. The polymer ﬁlms were irradiated either directly or by
application of a TEM grid (50 mm square patterns) as a photomask.
Photolysis of Ac1 and characterization of the photoproducts. Ac1 was
dissolved in deuterated dimethyl sulfoxide (5mgml 1) and subjected to irradia-
tion at 365 nm. The 1H NMR spectrum was recorded at predetermined time
intervals to record the kinetics of the photolysis process (Supplementary Figs 5 and
7). The photoproducts were also characterized by GC–MS (Supplementary Fig. 6).
Nanoparticles preparation. Polymer nanoparticles were prepared by adding
dropwise a polymer solution in THF (5%, 10ml) to 200ml water or phosphate-
buffered saline (PBS) (pH 7.4, 100mM). THF was completely removed under
vacuum before storing the NPs in the dark at  18 C.
Drug loading and release. A polymer/drug solution was prepared in methanol
(20ml, 1 g polymer, 50mg HP and 50mg CPT), which was left to form a thin ﬁlm
on the wall of a round bottom ﬂask by letting the solvent to evaporate slowly. Then,
PBS (50ml, pH 7.4, 100mM) was slowly added and left under gentle stirring for 2 h
in the dark. The NPs suspension was transferred in a cellulose dialysis bag and was
dialysed against excess PBS (1 l) for 8 h to remove the unloaded drugs. The total
drug loading was calculated based on equation (1).
%Drug loading¼Aðdrug amount detected)
Aðinitial drug added) ð1Þ
where A is the emission value obtained from ﬂuorescence spectroscopy of
known sample concentrations compared with standard calibration curve for HP
and CPT. Excitation at 350 nm was used throughout the experiments as at this
wavelength both drugs exhibit distinct emission bands and are easy to trace
(Supplementary Fig. 10).
The dialysis method was used for the drug release studies; a drug-loaded NP
suspension in PBS (10ml, pH 7.4) was dialysed against either acidic (500ml, pH
5.2) or basic buffer (500ml, pH 7.4) to probe the effect of particle hydrolysis. 1ml
aliquots were collected followed by subsequent buffer replenishing at predeter-
mined time intervals and the ﬂuorescence emission was measured to construct the
drug release proﬁles. The NP suspension was kept under constant gentle stirring.
Laser irradiation was conducted by irradiating the NP suspension directly from
above without disturbing the sampling setup. The drug release proﬁles were
normalized against the total CPT loaded for each sample.
A preliminary cell death study was conducted to determine the possible
cytotoxicity of the CPT released after 4 h. CPT samples were collected and the CPT
concentration was diluted to match the volume of the aliquots used in the control
cell death assays (Supplementary Fig. 11).
DLS. A dilute NP suspension in water was freshly prepared (0.5mgml 1) for the
DLS measurements. DLS was carried out on a custom-made system. The light
source was an Adlas DPY 315 II Nd:YAG laser (532 nm), polarized by two Glan-
Thomson polarizers (Halle, Berlin) placed before and after the sample. A colourless
lens was used to focus the beam onto the sample with a focal length of 200mm.
The scattered light was collected by an optical detector utilizing a 2F/2F system.
Two pinholes were used before the photomultiplier (Thorn EMI) to deﬁne the
scattering volume. The photon correlation was performed by an ALV-5000/E
photon correlator. The thermostatted sample cell was placed on a motor-driven
precision goniometer, which enabled the photomultiplier detector to be moved
accurately from 11 to 150 scattering angle. The sample was placed in a toluene
bath and the temperature was monitored by a thermostat. The resulting correlation
functions were ﬁtted with a stretched exponential function, Kohlrausch–Williams–
Watts from which the relaxation time was derived, and allowed to calculate the
diffusion coefﬁcient of the scatterer. The hydrodynamic diameters were calculated
from the Stokes–Einstein equation (2).
D¼ kBT
6pZr
ð2Þ
where D is the diffusion coefﬁcient, kB is Boltzmann’s constant, T is the absolute
temperature, Z is the viscosity of the solvent and r the hydrodynamic radius of the
spherical particle.
TEM. A drop of the diluted sample was placed on a carbon-coated copper grid
(400 Mesh) and was ﬁrst gently purged with a N2 steam and then left to dry in the
dark overnight. A JEOL JEM-2100 instrument at an electron accelerating voltage of
80 kV was employed for the measurements.
Cell culture and NP uptake. HeLa cells (purchased from ATCC) were suspended
to a concentration of 105 cellsml 1 in Dulbecco’s modiﬁed Eagle’s medium with
10% foetal bovine serum, and 1% antibiotic solution (GIBCO, Invitrogen, Karls-
ruhe, Germany). The cell suspension was transferred in a polystyrene-96-well plate
(180 ml in each well) and cultured at 37 C and 5% CO2. The cells were visually
examined regularly by optical microscopy and the culture was stopped after 48 h.
The cells were incubated with NPs by adding 20 ml of PBS NP suspension
(2mgml 1, loaded with HP and CPT) to a total volume of 200 ml. After incubating
for 4 h, the culture medium was replaced with fresh PBS and the cellular uptake
was measured on a plate reader. Equimolar amounts of free HP and CPT as
determined from the drug loading studies were used as control experiments to
probe the effect of drug encapsulation on the cellular uptake. The uptake studies
were performed in triplicate.
Polymer and photoproducts cytotoxicity. In the previously described protocol,
suitable control experiments were conducted to address the cytotoxicity of the
synthesized polymer and its photoproducts. The cells were suspended with the
polymer by adding 20 ml of a PBS polymer solution (2mgml 1). The cells were
also incubated with the polymer photoproducts as collected by a previously laser-
irradiated PBS polymer solution (2mgml 1, irradiated with a total dose of 1 J,
which was delivered at a frequency of 2Hz and ﬂuency of 20mJ cm 2). Subse-
quently, a live/dead cell counting assay was performed to assess the cytotoxicity of
the samples as described below.
Laser irradiation. After the cell uptake studies the six-well cell-containing plate
was transferred to a x-y positioning stage for laser irradiation. The cells were
irradiated with a Nd:YAG laser (532 nm) with a total dose of 1 J, which was
delivered as unfocused pulses with effective area of 0.7 cm2 at a frequency of 2Hz
and ﬂuency of 20mJ cm 2. This protocol was used as it allows for effective particle
photolysis and also permits adequate heat dissipation between pulses to avoid
photothermal cell death. The same setup was used for the control experiments
using the CW laser source at the same total dose.
Note: Although we did perform irradiation studies at 1,064 nm (Supplementary
Fig. 8) we had to increase the pulse ﬂuence to 50mJ cm 2 to probe effective
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particle photolysis, however, photothermal cell death was more pronounced and
hence more difﬁcult to deconvolute from the overall photochemical internalization
mechanism. We are currently exploring other chromophores adjacent to the acetals
that lower the ablation threshold at 1,064 nm–this research is currently ongoing
and the data will appear in another study.
Live/dead assay. The Vybrant cytotoxicity assay (Molecular Probes) was used as
it allows for accurate viability rate determination at low cell numbers (down to 500
cells according to the manufacturer) and does not interfere with the emission bands
of HP ad CPT. We followed the manufacturer’s protocol to perform the resazurin
assay, which is described in detail elsewhere27. The assay was performed in
triplicate to ensure statistical validity. The unpaired Student’s t-test was used to test
the statistical signiﬁcance of the viability rates.
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